ArticleFrontiers in psychiatry2026
Reduced gray matter in the prefrontal cortex and hippocampus: a potential neuroanatomical feature of insomnia comorbid with anxiety.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic insomnia disorder (CID) frequently comorbid with generalized anxiety disorder (GAD), and accurate identification of this comorbidity remains challenging. Neuroimaging-based gray matter measurements may provide objective features to improve precise identification. Objective: To investigate the potential value of gray matter features in distinguishing CID comorbid with GAD from CID or GAD alone. Methods: Voxel-based morphometry (VBM) and surface-based morphometry (SBM) were used to assess gray matter features. Comparisons were conducted among patients with CID (n = 46), GAD (n = 44), CID comorbid with GAD (n = 43), and healthy controls (n = 45). Results: CID comorbid with GAD was characterized by reduced gray matter volume in the prefrontal cortex and hippocampus. CID was characterized by reduced hippocampal volume and increased gyrification index (GI) in the prefrontal cortex. GAD was characterized by increased regional prefrontal cortex volume. These neuroanatomical features were associated with disease severity. Conclusion: Distinct gray matter features were observed among CID, GAD, and CID comorbid with GAD. These findings suggest that gray matter features may contribute to the identification of these conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.